These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9798075)

  • 41. Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.
    Bravermanová A; Viktorinová M; Tylš F; Novák T; Androvičová R; Korčák J; Horáček J; Balíková M; Griškova-Bulanova I; Danielová D; Vlček P; Mohr P; Brunovský M; Koudelka V; Páleníček T
    Psychopharmacology (Berl); 2018 Feb; 235(2):491-503. PubMed ID: 29302713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clozapine improves working memory updating in schizophrenia.
    Galletly CA; Clark CR; McFarlane AC
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):601-8. PubMed ID: 15905072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms.
    Kantrowitz JT; Epstein ML; Lee M; Lehrfeld N; Nolan KA; Shope C; Petkova E; Silipo G; Javitt DC
    Schizophr Res; 2018 Jan; 191():70-79. PubMed ID: 28318835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Analysis of reaction time in post-acute schizophrenia using electrophysiologic variables].
    Eichert V; Klosterkötter J
    Fortschr Neurol Psychiatr; 1996 Jul; 64(7):261-70. PubMed ID: 8765892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.
    Buchanan RW; Breier A; Kirkpatrick B; Ball P; Carpenter WT
    Am J Psychiatry; 1998 Jun; 155(6):751-60. PubMed ID: 9619146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
    Bilder RM; Goldman RS; Volavka J; Czobor P; Hoptman M; Sheitman B; Lindenmayer JP; Citrome L; McEvoy J; Kunz M; Chakos M; Cooper TB; Horowitz TL; Lieberman JA
    Am J Psychiatry; 2002 Jun; 159(6):1018-28. PubMed ID: 12042192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of olanzapine on auditory P300 in schizophrenia.
    Gonul AS; Suer C; Coburn K; Ozesmi C; Oguz A; Yilmaz A
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):173-7. PubMed ID: 12551741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia.
    Becker J; Gomes I; Ghisolfi ES; Schuch A; Ramos FL; Ehlers JA; Nora DB; Lara DR; da Costa JC
    Clin Neurophysiol; 2004 Feb; 115(2):396-401. PubMed ID: 14744582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys.
    Linn GS; Negi SS; Gerum SV; Javitt DC
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):234-9. PubMed ID: 12845408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A tale of two sites: Differential impairment of frequency and duration mismatch negativity across a primarily inpatient versus a primarily outpatient site in schizophrenia.
    Lee M; Sehatpour P; Dias EC; Silipo GS; Kantrowitz JT; Martinez AM; Javitt DC
    Schizophr Res; 2018 Jan; 191():10-17. PubMed ID: 28779851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term olanzapine treatment and p300 parameters in schizophrenia.
    Molina V; Muñoz F; Martín-Loeches M; Casado P; Hinojosa JA; Iglesias A
    Neuropsychobiology; 2004; 50(2):182-8. PubMed ID: 15292675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain potential evidence for an auditory sensory memory deficit in schizophrenia.
    Catts SV; Shelley AM; Ward PB; Liebert B; McConaghy N; Andrews S; Michie PT
    Am J Psychiatry; 1995 Feb; 152(2):213-9. PubMed ID: 7840354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.
    Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC
    Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of risperidone on event-related potentials in schizophrenic patients.
    Iwanami A; Okajima Y; Isono H; Shinoda J; Kasai K; Hata A; Fukuda M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2001 Mar; 34(2):73-9. PubMed ID: 11302567
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensory deficits and distributed hierarchical dysfunction in schizophrenia.
    Leitman DI; Sehatpour P; Higgins BA; Foxe JJ; Silipo G; Javitt DC
    Am J Psychiatry; 2010 Jul; 167(7):818-27. PubMed ID: 20478875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of differential response to clozapine and haloperidol. Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Lawson W; Crayton J; Cramer J; Xu W; Thomas J; Stolar M; Charney D
    Biol Psychiatry; 1998 Sep; 44(6):475-82. PubMed ID: 9777179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
    Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
    Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
    Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of auditory and visual training on the mismatch negativity in schizophrenia.
    Kärgel C; Sartory G; Kariofillis D; Wiltfang J; Müller BW
    Int J Psychophysiol; 2016 Apr; 102():47-54. PubMed ID: 26968496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.